quinoxalines has been researched along with fluorescein in 6 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 5 (83.33) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 1 (16.67) | 2.80 |
| Authors | Studies |
|---|---|
| Larsson, LI | 1 |
| Miller, J; Uttamchandani, D; Wilson, CG | 1 |
| Larsson, LI; Tsukamoto, H | 1 |
| Li, W; Massey, SC; Trexler, EB | 1 |
| Miller, J; Uttamchandani, D; Wilson, CG; Wilson, WS | 1 |
| Doura, T; Hamachi, I; Kiyonaka, S; Komatsu, K; Ojima, K; Shiraiwa, K; Soga, K; Takato, M; Yuzaki, M | 1 |
2 trial(s) available for quinoxalines and fluorescein
| Article | Year |
|---|---|
Aqueous humor flow in normal human eyes treated with brimonidine and timolol, alone and in combination.
Topics: Administration, Topical; Adrenergic alpha-Agonists; Adrenergic beta-Antagonists; Adult; Aqueous Humor; Brimonidine Tartrate; Double-Blind Method; Drug Therapy, Combination; Female; Fluorescein; Fluorophotometry; Humans; Intraocular Pressure; Male; Middle Aged; Ophthalmic Solutions; Quinoxalines; Timolol; Tonometry, Ocular | 2001 |
Aqueous humor flow in normal human eyes treated with brimonidine and dorzolamide, alone and in combination.
Topics: Administration, Topical; Adult; Antihypertensive Agents; Aqueous Humor; Brimonidine Tartrate; Cornea; Double-Blind Method; Drug Therapy, Combination; Female; Fluorescein; Fluorophotometry; Humans; Intraocular Pressure; Male; Manometry; Middle Aged; Ophthalmic Solutions; Quinoxalines; Sulfonamides; Thiophenes | 2004 |
4 other study(ies) available for quinoxalines and fluorescein
| Article | Year |
|---|---|
Minimally invasive spectroscopic system for intraocular drug detection.
Topics: Adrenergic alpha-Agonists; Anterior Chamber; Anti-Bacterial Agents; Aqueous Humor; Brimonidine Tartrate; Contact Lenses; Contact Lenses, Hydrophilic; Contrast Media; Equipment Design; Eye; Fluorescein; Humans; Quinoxalines; Spectrum Analysis; Tetracycline | 2002 |
Simultaneous contribution of two rod pathways to AII amacrine and cone bipolar cell light responses.
Topics: Amacrine Cells; Animals; Benzodiazepines; Benzothiadiazines; Diagnostic Imaging; Dose-Response Relationship, Radiation; Electric Stimulation; Excitatory Amino Acid Antagonists; Excitatory Postsynaptic Potentials; Female; Fluorescein; GABA Antagonists; Glycine Agents; In Vitro Techniques; Light; Male; Membrane Potentials; Models, Biological; Neurons; Patch-Clamp Techniques; Picrotoxin; Quinoxalines; Rabbits; Retina; Retinal Rod Photoreceptor Cells; Strychnine; Synapses; Synaptic Transmission; Visual Pathways | 2005 |
Minimally invasive, direct, real time measurement of drug concentration in the anterior eye.
Topics: Absorption; Administration, Topical; Adult; Animals; Anterior Chamber; Brimonidine Tartrate; Contact Lenses; Cornea; Fluorescein; Humans; Male; Middle Aged; Ophthalmic Solutions; Quinoxalines; Rabbits; Spectrometry, Fluorescence | 2005 |
Ligand-directed two-step labeling to quantify neuronal glutamate receptor trafficking.
Topics: Animals; Cerebral Cortex; Excitatory Amino Acid Antagonists; Fluorescein; Fluorescent Dyes; Gene Expression; Half-Life; HEK293 Cells; Hippocampus; Humans; Ligands; Mice; Mice, Inbred ICR; Neurons; Primary Cell Culture; Protein Transport; Quinoxalines; Rats; Rats, Sprague-Dawley; Receptors, AMPA; Receptors, N-Methyl-D-Aspartate; Staining and Labeling | 2021 |